CVS Health Corporation CVS

89.13 4.08 4.80% as of 25 Sep
Market cap
$108.5B
P/E
23.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

CVS Health Corporation (CVS) Return on equity

CVS Health Corporation's return on equity over the twelve months to 30 June 2026 was 6.21%, up 3.9 percentage points from fiscal 2025 (2.34%). Over the past ten years it has ranged from −1.23% (fiscal 2018) to 17.8% (fiscal 2017); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 12.5% and above the Healthcare sector median of −32.0%.

Return on equity, annual

Annual

Period Return on equity Change (points)
FY2025 2.34% (3.72)
FY2024 6.06% (5.18)
FY2023 11.2% 5.38
FY2022 5.86% (5.17)
FY2021 11.0% 0.30
FY2020 10.7% (0.08)
FY2019 10.8% 12.04
FY2018 −1.23% (19.00)
FY2017 17.8% 3.41
FY2016 14.4% 0.43

Against its own ten years

Low −1.23% High 17.8%
Ten-year median 10.8%
Current reading's percentile 18

Return on equity against peers

Company Return on equity
OSCR Oscar Health, Inc. compare 34.2%
CI Cigna Group compare 15.4%
UNH UnitedHealth Group Incorporated compare 13.8%
ELV Elevance Health, Inc. compare 11.2%
HUM Humana Inc. compare 6.81%
CVS CVS Health Corporation 6.21%
MOH Molina Healthcare, Inc compare −0.16%
CLOV Clover Health Investments, Corp. compare −5.10%
CNC Centene Corporation compare −20.4%
Healthcare Plans industry median 12.5%
Healthcare sector median −32.0%
Market median 1.76%

What Return on equity is

ROE shows how much profit a company earns for its shareholders on the equity they have in the business.

Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)

The full definition of Return on equity →

More on CVS